info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Ventilator-associated pneumonia (VAP) Companies

Companies specializing in Ventilator-associated pneumonia (VAP) focus on innovative solutions for preventing and managing pneumonia in ventilated patients. Committed to patient care, these organizations develop advanced technologies to mitigate the risks associated with ventilator support, ensuring optimal respiratory health.

Ventilator associated pneumonia Key Companies

 

Latest Ventilator associated pneumonia Companies Update


Pulmonetics acquires VAP detection startup, RespiraTech deal strengthens Pulmonetics' offerings with RespiraTech's AI-powered early VAP detection technology, aiming to prevent infections before they arise.


Roche partners with Veridian Medical collaboration combines Roche's diagnostic expertise with Veridian's continuous glucose monitoring technology, potentially leading to new tools for monitoring patients at risk of VAP.


Vapotherm and PulmoTech are developing breathalyzer-like devices for rapid and non-invasive VAP diagnosis, reducing reliance on invasive procedures.


Sepsis.io and EarlySight are utilizing AI to analyze patient data and predict VAP risk, enabling proactive interventions like personalized ventilation settings.


List of Ventilator associated pneumonia Key Companies in the Market



  • Adenium Biotech ApS (Denmark)

  • Merck & Co. Inc. (US)

  • AstraZeneca (UK)

  • MedImmune (US)

  • Nabriva Therapeutics AG (Ireland)

  • Thermo Fisher Scientific (US)

  • Bayer AG (Germany)

  • Wockhardt (India)

  • Shionogi Inc. (Japan)

  • Cardeas Pharma (US)


Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.